Dosage specifications of F/TAF and suggestions for adjusting the dosage according to different situations

F/TAF is a compound antiviral drug mainly used to treat adults and adolescents with HIV-1 infection. Its ingredients include fultegravir fumarate (F/TAF) and tenofovir alafenamide, which block viral replication by inhibiting the activity of viral reverse transcriptase. Standard dosage is usually one tablet taken orally once daily with or without food. Patients should maintain regular medication and never stop taking the medication on their own to ensure that the drug maintains effective blood concentration and reduce the risk of drug resistance.

Dacovail should be used with caution in patients with renal insufficiency. For patients with mild to moderate renal impairment (eGFR 30–89 mL/min/1.73m²), the usual dose can usually be maintained, but renal function and serum creatinine need to be monitored regularly. For patients with severe renal insufficiency (eGFR <30 mL/min/1.73m²) or patients receiving dialysis, a professional physician should be consulted before use. There is currently insufficient data to support routine medication in this group, so dose adjustment or alternative options may be required.

For pregnant women, lactating women and elderly patients, Dacovail should be used under the guidance of a doctor. Pregnant and lactating patients need to weigh the maternal treatment benefits against the risks to the fetus or infant, and adjust the dosage or monitor drug blood concentrations if necessary. Since elderly patients may be accompanied by decreased renal function or multiple concomitant medications, potential drug interactions need to be carefully evaluated and dosage or monitoring frequency should be flexibly adjusted based on tolerance.

During long-term use of Dakovo, patients should regularly review hematological indicators, liver function and viral load to evaluate the efficacy and detect adverse reactions in a timely manner. If abnormal liver function, lactic acidosis or severe gastrointestinal discomfort occurs, you need to contact your doctor immediately to adjust the dose or suspend treatment. By standardizing medication, regular monitoring, and individualized dose adjustment, patients can maximize the therapeutic effect while reducing the risk of adverse events, achieving safe and effective antiviral treatment.

Reference materials:https://www.drugs.com/